Related Experiment Video

Updated: Aug 17, 2026

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamics

Giulia Marchetti1, Luca Meroni, Chiara Molteni

  • 1Institute of Infectious Diseases and Tropical Medicine, Luigi Sacco Hospital, University of Milan, Italy.

AIDS (London, England)
|April 13, 2004
PubMed

Insights

Interleukin-2 (IL-2) immunotherapy selectively boosts CD4 T cell recovery in HIV patients more than CD8 T cells. This suggests IL-2 influences T cell dynamics, impacting immune reconstitution strategies.

Area of Science:

  • Immunology
  • Virology
  • Clinical Medicine

Background:

  • HIV infection differentially impacts CD4 and CD8 T cell recovery.
  • Interleukin-2 (IL-2) driven immune reconstitution selectively promotes CD4 T cell expansion via unknown mechanisms.

Purpose of the Study:

  • To investigate the effect of IL-2 on T cell homeostasis.
  • To analyze the differential impact of IL-2 immunotherapy on CD4 and CD8 T cell dynamics in HIV patients.

Main Methods:

  • A randomized trial involving 15 HIV-positive patients, comparing IL-2 immunotherapy plus HAART against HAART alone.
  • Longitudinal measurement of CD4/CD8 counts, T cell proliferation (Ki67), activation (CD38), and thymic output (TRECs) via flow cytometry.
  • Statistical analysis using the Wilcoxon test to compare treatment groups over a 48-week follow-up period.

Main Results:

  • IL-2 significantly increased CD4 T cell counts compared to HAART alone (P < 0.01).
  • IL-2 enhanced CD4 T cell proliferation (Ki67+) and CD4 TREC levels, indicating increased thymic output.
  • No significant changes were observed in CD8 T cell counts, proliferation, or TRECs with IL-2 treatment.

Conclusions:

  • IL-2 immunotherapy demonstrates a differential effect on CD4 and CD8 T cell homeostasis in HIV patients.
  • The findings suggest IL-2 promotes immune reconstitution through complex interactions between T cell compartments.
  • These results have significant implications for optimizing immunotherapeutic strategies in HIV management.
Abstract

More Related Videos

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model07:49

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.